Navigation Links
FDA Approves New Medical Device for Form of Brain Cancer
Date:4/15/2011

SILVER SPRING, Md., April 15, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme (GBM) that recurs or progresses after receiving chemotherapy and radiation therapy.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Brain tumors are the growth of abnormal cells in the brain tissue. According to the National Cancer Institute, each year about 19,000 people in the United States are diagnosed with primary brain cancers. In 2010, there were 13,140 deaths from brain and other nervous system cancers in the United States.

GBM is the most common primary brain cancer. The brain tumor is highly resistant to standard treatments such as surgery, radiation and chemotherapy.

When using the NovoTTF-100A System, a health care professional places electrodes on the surface of the patient's scalp to deliver low-intensity, changing electrical fields called "tumor treatment fields" (TTFs) to the tumor site. The unique shape and electrical characteristics of dividing tumor cells make them susceptible to damage when exposed to TTF, which could stop tumor growth.  

The device is portable and can be powered with batteries or plugged into an electrical outlet. Patients can use the device at home, allowing them to continue their normal daily activities.  

"Recurrent glioblastoma multiforme is a devastating form of brain cancer that often eludes standard treatments," said Jeffrey Shuren, M.D., J.D., director of the FDA's Center for Devices and Radiological Health. "The agency's approval of the NovoTTF-100A System shows FDA's commitment to innovative new devices that provide patients with other treatment options."

The FDA based its approval of the NovoTTF 100A System on results from a single international clinical study in 237 patients with r
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors
2. FDA Approves Horizant To Treat Restless Legs Syndrome
3. FDA Approves New Treatment for Rare Form of Thyroid Cancer
4. FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Groups Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
5. FDA Approves Hyperopia Application for the MEL 80 Excimer Laser from Carl Zeiss Meditec
6. FDA Approves New Treatment for a Type of Late-Stage Skin Cancer
7. FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals 50 to 59 Years of Age
8. FDA Approves Gadavist for Central Nervous System Scans
9. U.S. FDA Approves Bayers Gadavist™ (Gadobutrol) Injection for MRI of the Central Nervous System
10. FDA Approves Device to Maintain Blood Flow During Artery Bypass Brain Surgery
11. FDA Approves BENLYSTA® for Lupus in Breakthrough for Millions of Sufferers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Mass. , May 23, 2013  Haemonetics Corporation (NYSE: ... Lindop , CFO & EVP-Business Development, will present at ... Conference in Boston, MA on May ... http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may access ... About Haemonetics Haemonetics (NYSE: ...
(Date:5/23/2013)... , May 23, 2013 Hearing health affects a ... younger, and remain socially and professionally engaged, he should address ... overriding message that the Better Hearing Institute (BHI) ... National Men,s Health Week , which leads up to ... runs from June 10 through June 16. ...
(Date:5/23/2013)... recently published clinical study conducted at TOPS Comprehensive Breast ... that 3D mammography (breast tomosynthesis) significantly reduces unnecessary recalls ... study, "Implementation of Breast Tomosynthesis in a Routine Screening ... Stephen L. Rose , MD, and published in ... Roentgenology (AJR). The AJR is the scientific journal ...
Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3
... Reportlinker.com announces that a new ... its catalogue: Germany ... rules set to negatively impact drug ... http://www.reportlinker.com/p0360217/Germany-Pharmaceutical-Market-Overview-–-New-pricing-rules-set-to-negatively-impact-drug-sales-both-domestically-and-internationally.html ...
... 2011 BD (Becton, Dickinson and Company) (NYSE: ... a live webcast of its first fiscal quarter 2011 earnings ... a.m. (ET).  BD will issue a press release detailing the ... 2011. The webcast of the conference call, along ...
Cached Medicine Technology:Reportlinker Adds Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally 2
(Date:5/25/2013)... (PRWEB) May 25, 2013 A disorder ... type of peripheral neuropathy. According to neuropathy expert doctor ... it is estimated that the disorder affects almost 50% ... complication arising from Diabetes. The high blood sugar levels ... and patients suffering from it usually tend to have ...
(Date:5/25/2013)... States (PRWEB) May 25, 2013 ... largest underground shelter company in the US and ... underground structures for over 35 years. M.E. and ... U.S. Handbook of NBC Weapon Fundamentals and Shelter ... United States’ bible on shelter engineering. McCarthy is ...
(Date:5/25/2013)... York, New York (PRWEB) May 25, 2013 ... who allegedly suffered serious, life-threatening episodes of internal bleeding while ... litigation underway in U.S. District Court, Southern District of Illinois, ... the Court’s website, 818 Pradaxa side effect claims had ... 2013. That’s up from 705 claims reported by the ...
(Date:5/25/2013)... Many orthodontists have thought about moving ... that cloud is. Most people would naturally assume ... provide their cloud service and support would own and ... they're selling, they'd be wrong. Cloud providers lease ... redundant facility that houses servers and related equipment to ...
(Date:5/25/2013)... IBISWorld estimates that revenue for the ... rate of 28.7% to $1.0 billion in the five years ... and 2008, no new cell therapy products were introduced, according ... during that period. In the years since, however, the Food ... factor contributed to the industry's fast growth during the five ...
Breaking Medicine News(10 mins):Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3
... antiretroviral treatment for HIV have been recorded and quantified by ... week in The Lancet. If efficacy levels of drug combinations ... of the drugs. Therefore, the data may be useful as ... treatment regimens. // ,Dr Jacques Fellay from the ...
... self-contained artificial heart in a 59-year-old man more than ... installed a second such device in a 70-year-old man. ... in intensive care at Jewish Hospital in Louisville, the ... self-contained mechanical heart, made by Abiomed Inc. of Danvers, ...
... from 'keyhole' surgery, according to a new study. Non-invasive - ... number of operations. It scores because there is no big ... surgery involves a tiny incision through which miniature instruments are ... through the operation. // ,It's an advance ...
... Antioxidants may be able to treat the neurological problems ... in the US suffer from kidney failure, which is ... Kidney failure often leads to neurological complications like fatigue, ... ,Researchers at the University of California at ...
... of hepatitis virus not believed to cause illness may improve ... AIDS. In two new studies, HIV-positive people who were also ... than other people infected with HIV. Researchers suspect that hepatitis ... survival by keeping HIV from replicating as often. // ...
... terrorist acts in New York and Washington DC, air ... for several days, which severely affected the production and ... air due to their specific nature. These products are ... radioactive component, and are used in diagnosis or therapy ...
Cached Medicine News:
... an automated multiplexing platform that uses advanced ... sequence detection and pharmacogenetics applications. Multiple samples ... an open and flexible electronic microarray, the ... all tests sites have been utilized. This ...
Cable connections for 5 different adapters: Storz, ACMI, Pentax, Wolf and Olympus....
... & Y Coordinates At The 6 & 9 ... Diameter & 13mm Outer Diameter Radial Axis Marks ... With Hand-Held Markers By Mounting The Device To ... A More Perfect Mark. , ,Etched Calibration ...
... • V-shaped bottom allows easy withdrawal ... facilitate pour-out ,• Nesting ring allows ... Basin designed for 4, 8, and 12 ... bottom permits withdrawal of practically all of ...
Medicine Products: